Sprycel Market

Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).

Sprycel Market contains market size and forecasts of Sprycel in global, including the following market information:

• Global Sprycel Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Sprycel Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Sprycel companies in 2021 (%)

The global Sprycel market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

20mg Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Sprycel include Bristol-Myers Squibb and LUCIUS Pharma etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Sprycel manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Sprycel Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sprycel Market Segment Percentages, by Type, 2021 (%)

• 20mg
• 50mg
• 70mg

Global Sprycel Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sprycel Market Segment Percentages, by Application, 2021 (%)

• CML
• ALL

Global Sprycel Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Sprycel Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Sprycel revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Sprycel revenues share in global market, 2021 (%)
• Key companies Sprycel sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Sprycel sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Bristol-Myers Squibb
• LUCIUS Pharma